chr20-3866015-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_020746.5(MAVS):c.1491C>T(p.Ala497=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00793 in 1,612,878 control chromosomes in the GnomAD database, including 85 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.011 ( 17 hom., cov: 33)
Exomes 𝑓: 0.0077 ( 68 hom. )
Consequence
MAVS
NM_020746.5 synonymous
NM_020746.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -3.05
Genes affected
MAVS (HGNC:29233): (mitochondrial antiviral signaling protein) This gene encodes an intermediary protein necessary in the virus-triggered beta interferon signaling pathways. It is required for activation of transcription factors which regulate expression of beta interferon and contributes to antiviral innate immunity. [provided by RefSeq, Jul 2020]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.66).
BP6
Variant 20-3866015-C-T is Benign according to our data. Variant chr20-3866015-C-T is described in ClinVar as [Benign]. Clinvar id is 771779.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-3.05 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0105 (1606/152288) while in subpopulation AFR AF= 0.0201 (834/41572). AF 95% confidence interval is 0.0189. There are 17 homozygotes in gnomad4. There are 769 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High AC in GnomAd4 at 1606 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MAVS | NM_020746.5 | c.1491C>T | p.Ala497= | synonymous_variant | 7/7 | ENST00000428216.4 | |
MAVS | NM_001206491.2 | c.1068C>T | p.Ala356= | synonymous_variant | 6/6 | ||
MAVS | NM_001385663.1 | c.1068C>T | p.Ala356= | synonymous_variant | 8/8 | ||
MAVS | NR_037921.2 | n.1455C>T | non_coding_transcript_exon_variant | 6/6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MAVS | ENST00000428216.4 | c.1491C>T | p.Ala497= | synonymous_variant | 7/7 | 1 | NM_020746.5 | P1 | |
MAVS | ENST00000416600.6 | c.1068C>T | p.Ala356= | synonymous_variant | 6/6 | 1 |
Frequencies
GnomAD3 genomes AF: 0.0105 AC: 1603AN: 152170Hom.: 17 Cov.: 33
GnomAD3 genomes
AF:
AC:
1603
AN:
152170
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00732 AC: 1812AN: 247642Hom.: 12 AF XY: 0.00684 AC XY: 922AN XY: 134758
GnomAD3 exomes
AF:
AC:
1812
AN:
247642
Hom.:
AF XY:
AC XY:
922
AN XY:
134758
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00766 AC: 11181AN: 1460590Hom.: 68 Cov.: 32 AF XY: 0.00760 AC XY: 5522AN XY: 726634
GnomAD4 exome
AF:
AC:
11181
AN:
1460590
Hom.:
Cov.:
32
AF XY:
AC XY:
5522
AN XY:
726634
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0105 AC: 1606AN: 152288Hom.: 17 Cov.: 33 AF XY: 0.0103 AC XY: 769AN XY: 74468
GnomAD4 genome
AF:
AC:
1606
AN:
152288
Hom.:
Cov.:
33
AF XY:
AC XY:
769
AN XY:
74468
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
8
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 20, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at